EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiome–Sleep Crosstalk: Mechanistic Pathways, Dysbiosis Signatures, and Microbiome‐Based Interventions

Ghaleb Oriquat, Shaker Al-Hasnaawei, Hayjaa Mohaisen Mousa, Malathi H, Siya Singla, Samir Sahoo iD, Vimal Arora, Ashish Singh Chauhan, Mehrdad Nourizadeh

Brain and Behavior · 2026-06 · 16 (6)

DOI: 10.1002/brb3.71525 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain and Behavior, online erschienen am 04.06.2026. Verfasst von Ghaleb Oriquat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Sleep, Sleep Wake Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This review examines the bidirectional relationship between sleep regulation and the gut microbiome within the gut–brain axis, with particular attention to mechanistic pathways, disorder‐associated dysbiosis patterns, and microbiome‐targeted interventions in insomnia, obstructive sleep apnea, circadian disruption, and sleep loss‐related states.

Methods

We critically synthesized evidence from both human and preclinical studies, focusing on microbial metabolites, neuroimmune and neuroendocrine signaling, circadian regulation, and intervention‐based approaches. Rather than only summarizing individual studies, we aimed to distinguish associative human findings from mechanistic evidence derived mainly from animal models.

Results

Current evidence supports a bidirectional link between sleep and the gut microbiome. Microbiota‐derived metabolites, particularly short‐chain fatty acids, tryptophan‐related metabolites, and gamma‐aminobutyric acid, appear to influence sleep homeostasis through effects on intestinal barrier integrity, inflammatory tone, stress‐axis regulation, and central signaling pathways. Across sleep disorders, recurrent microbial patterns include reduced abundance of potentially beneficial taxa such as Bifidobacterium and Faecalibacterium and enrichment of pro‐inflammatory or stress‐associated taxa, although these signatures are not yet fully consistent across cohorts or disorders. In humans, most data remain observational and support association rather than causation, whereas stronger mechanistic support comes from experimental models of sleep deprivation, intermittent hypoxia, and microbiota transfer. Early intervention studies suggest that selected probiotics, prebiotics, dietary modulation, and related microbiome‐directed strategies may improve sleep‐related outcomes, but the magnitude and reproducibility of these effects remain uncertain.

Conclusion

The gut microbiome represents a promising mechanistic and therapeutic target in sleep medicine, but clinical translation is still constrained by heterogeneity in microbiome profiling, sleep phenotyping, intervention design, and strain‐specific effects. Future work should prioritize longitudinal human studies, standardized outcome measures, and mechanistically informed trials capable of identifying clinically actionable and biologically credible microbiome signatures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisGastrointestinal MicrobiomeSleepSleep Wake DisordersHumansAnimalsBrain

Stichwörter der Autor:innen

dysbiosisgut–brain axisneuroinflammationpsychobioticsshort‐chain fatty acidssleep disturbances

Autor:innen und Institutionen

  • Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
  • College of Pharmacy, Islamic University, Najaf, Iraq.
  • Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
  • Department of Medicinal Chemistry, Al-Turath University, Baghdad, Iraq.
  • Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
  • Centre for Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.

ORCID-Profile: Samir Sahoo

Zitieren

APA

Oriquat, G., Al-Hasnaawei, S., Mousa, H. M., Malathi H, Singla, S., Sahoo, S., Arora, V., Chauhan, A. S., & Nourizadeh, M. (2026). Gut Microbiome–Sleep Crosstalk: Mechanistic Pathways, Dysbiosis Signatures, and Microbiome‐Based Interventions. Brain and Behavior, 16(6). https://doi.org/10.1002/brb3.71525

Vancouver

Oriquat G, Al-Hasnaawei S, Mousa HM, Malathi H, Singla S, Sahoo S, et al. Gut Microbiome–Sleep Crosstalk: Mechanistic Pathways, Dysbiosis Signatures, and Microbiome‐Based Interventions. Brain and Behavior. 2026;16(6). doi:10.1002/brb3.71525

BibTeX
@article{Oriquat2026,
  author = {Oriquat, Ghaleb and Al-Hasnaawei, Shaker and Mousa, Hayjaa Mohaisen and Malathi H and Singla, Siya and Sahoo, Samir and Arora, Vimal and Chauhan, Ashish Singh and Nourizadeh, Mehrdad},
  title = {Gut Microbiome–Sleep Crosstalk: Mechanistic Pathways, Dysbiosis Signatures, and Microbiome‐Based Interventions},
  journal = {Brain and Behavior},
  year = {2026},
  volume = {16},
  number = {6},
  doi = {10.1002/brb3.71525}
}
Kostenlos starten →